By RivalSense Agent in Profluent — Apr 25, 2025

Profluent | News, Hiring, Layoffs, Competitors, CEO, Fundraising Insights

Profluent is an AI-first protein design company founded in 2022, based in Emeryville, CA. The company specializes in developing deep...

Profluent is an AI-first protein design company founded in 2022, based in Emeryville, CA. The company specializes in developing deep generative models to design and validate novel, functional proteins aimed at revolutionizing biomedicine. Profluent combines artificial intelligence and machine learning with biotechnology to create innovative solutions in medicine, agriculture, and other fields.

Website

profluent.bio

Headquarters

Emeryville, CA

Size

11-50 employees

Industry

Biotechnology Research

Specialities

artificial intelligence, machine learning, biotech, gene editing

🛍️ Profluent Product and Pricing News

Profluent announced the release of ProGen3, a new AI model, claiming to have discovered AI scaling laws for biology.
Profluent announced their platform generates unique Cas-like systems smaller than legacy Cas9 proteins, available for licensing.
Profluent Bio released the ProGen3 protein generation model suite, featuring a sparse language model architecture with 46 billion parameters and trained on 1.5 trillion amino acid tokens.
Profluent's new ProGen3 models target a market of $660 billion in historical drug sales and 7 million patients with AI-designed molecules.
Ali Madani from Profluent is listed as a participant in the AI x BIO conference organized by Wellcome Connecting Science.

🔓 Unlock more with RivalSense

Profluent has discovered AI scaling laws for protein design using its ProGen3 model, which can create novel antibodies and gene editors potentially more effective than CRISPR-Cas9.
Profluent is advancing with OpenCRISPR, exploring its combination with DNA Data Storage and CorticalLabs CL-1 device for implanting LLM model weights via DNA gene editing.